| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.48 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |